4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001019056-20-000441
Options or other derivatives
- CEO and President acquired 21,438 shares (grant or award)
- CEO and President returned 49,348 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| White Marvin L CEO and President | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −2,545 | 0 | D | ||
| White Marvin L CEO and President | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −14,319 | 0 | D | ||
| White Marvin L CEO and President | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −5,414 | 0 | D | ||
| White Marvin L CEO and President | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −5,414 | 0 | D | ||
| White Marvin L CEO and President | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −10,828 | 0 | D | ||
| White Marvin L CEO and President | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −10,828 | 0 | D | ||
| White Marvin L CEO and President | 2020-07-27 | Grant or award · Stock Option (right to buy) | +16,625 | 16,625 | D | ||
| White Marvin L CEO and President | 2020-07-27 | Grant or award · Stock Option (right to buy) | +4,813 | 4,813 | D | ||
Loading xslF345X03/white.xml…